The nucleotide sequence of the Pseudomonas aeruginosa pyrE-crc-rph region and the purification of the crc gene product. by MacGregor, Carolyn H. et al.
JOURNAL OF BACTERIOLOGY, Oct. 1996, p. 5627–5635 Vol. 178, No. 19
0021-9193/96/$04.0010
Copyright q 1996, American Society for Microbiology
The Nucleotide Sequence of the Pseudomonas aeruginosa pyrE-crc-rph
Region and the Purification of the crc Gene Product
CAROLYN H. MACGREGOR, SHIWANI K. ARORA,† PAUL W. HAGER, MARY BETH DAIL,
AND PAUL V. PHIBBS, JR.*
Department of Microbiology and Immunology, East Carolina University School of Medicine,
Greenville, North Carolina 27858
Received 13 March 1995/Accepted 31 July 1996
The gene (crc) responsible for catabolite repression control in Pseudomonas aeruginosa has been cloned and
sequenced. Flanking the crc gene are genes encoding orotate phosphoribosyl transferase (pyrE) and RNase PH
(rph). New crc mutants were constructed by disruption of the wild-type crc gene. The crc gene encodes an open
reading frame of 259 amino acids with homology to the apurinic/apyrimidinic endonuclease family of DNA
repair enzymes. However, crc mutants do not have a DNA repair phenotype, nor can the crc gene complement
Escherichia coli DNA repair-deficient strains. The crc gene product was overexpressed in both P. aeruginosa and
in E. coli, and the Crc protein was purified from both. The purified Crc proteins show neither apurinic/
apyrimidinic endonuclease nor exonuclease activity. Antibody to the purified Crc protein reacted with proteins
of similar size in crude extracts from Pseudomonas putida and Pseudomonas fluorescens, suggesting a common
mechanism of catabolite repression in these three species.
The genus Pseudomonas is noteworthy for its diversity in
habitat and physiology. Some Pseudomonas strains are able to
use over 100 organic compounds as the sole or principal source
of carbon. Pseudomonas aeruginosa can utilize at least 80 dif-
ferent organic compounds (41). A mechanism of catabolite
repression control exists in these organisms (18) which pre-
vents them from wasting energy maintaining the enzymes for
all these catabolic pathways and ensures the preferential utili-
zation of the most efficient source of carbon and energy. Such
a regulatory mechanism has also been identified in the enteric
bacteria (20) and in Bacillus spp. (6).
In the enteric bacteria, the molecular mechanism of catab-
olite repression control involves a catabolite activator protein
(Cap) which, when bound to cyclic AMP (cAMP), interacts
with promoter regions of regulated genes to facilitate the bind-
ing of RNA polymerase, thereby initiating transcription (20).
In the presence of glucose, the cAMP pool is lowered, Cap is
not bound, and the regulated genes are not transcribed (i.e.,
they are repressed). The effect of glucose on cAMP pools is
mediated by components of the phosphoenolpyruvate phos-
photransferase system which also serve to activate adenylate
cyclase (33). Since the initial identification of these regulatory
components, catabolite repression has proven to be a global
mechanism in the enteric bacteria, affecting at least 28 separate
promoters which regulate biosynthetic as well as catabolic
operons (7). It also has been found to act as a negative regu-
lator as well as a positive regulator (1, 7, 23, 24).
In Bacillus spp. catabolite repression is not mediated by
glucose, nor is cAMP involved (6, 37, 40). Genetic evidence has
implicated the catabolite control protein (CcpA), a member of
the GalR family of repressor proteins (6), Hpr, a component of
the phosphoenolpyruvate phosphotransferase system (9), and
a cis-acting DNA sequence (CRE) (15, 48). Recent work has
shown that HPr specifically phosphorylated at Ser-46 forms a
complex with CcpA capable of protecting the CRE from
DNase digestion (11), suggesting a global regulatory model for
catabolite repression in Bacillus spp. (11, 14).
In P. aeruginosa and Pseudomonas putida, acetate and inter-
mediates of the tricarboxylic acid cycle are the strongest re-
pressing substrates, although glucose can cause repression of
some catabolic pathways, such as that of mannitol utilization
(38). Further, neither cAMP nor adenylate cyclase appears to
play a role in catabolite repression control (29, 38). To date,
the molecular mechanism of catabolite repression control in
these organisms is completely unknown. Recently we described
the isolation of the first mutants in catabolite repression con-
trol (crc) in P. aeruginosa (47). Their phenotype is the failure to
repress multiple independently regulated pathways when
grown in the presence of tricarboxylic acid cycle intermediates
(47). We subsequently cloned a gene which restores wild-type
regulation to these mutants (19). Here we report the nucleo-
tide sequences for the crc region, the comparison of the de-
rived protein sequences to other known proteins, and the sig-
nificance of this comparison to the function of the Crc protein.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Bacterial strains and plasmids used in
this study are listed in Table 1. P. aeruginosa was grown at 378C in basal salts
medium (BSM) (16) or in Luria-Bertani (LB) medium (22). Pseudomonas fluo-
rescens and P. putida were grown at 308C in LB medium. Antibiotics were used
at the following concentrations: tetracycline (TET), 100 mg/ml for P. aeruginosa
and 20 mg/ml for Escherichia coli; carbenicillin (CB), 500 mg/ml for P. aeruginosa;
ampicillin (AMP), 100 mg/ml for E. coli.
Mutant construction and transfer of plasmids. Pseudomonas strain PAO8020,
carrying the crc mutation, was constructed as follows: from the 2-kb insert of
plasmid pPZ353, a 0.3-kb AccI fragment was replaced with a Tcr cassette (see
Fig. 1 for diagram; pPZ353 is identical to pPZ354 except that it lacks an oriV).
The truncated crc gene containing the Tcr cassette was cut from this plasmid and
inserted into pUC19mob to produce pPZ407. pUC19mob carries the mob region
of pRP4 (26) which acts in trans with the tra genes carried on the chromosome
of E. coli S17-1 to mobilize the conjugal transfer of this plasmid into a broad
range of gram-negative bacteria (39). Donor cells (S17-1 containing pPZ407) and
recipient cells (P. aeruginosa PAO1) were grown to log phase in LB medium.
These cells were mixed in a 1:1 ratio, and 2 ml of this mix was filtered onto a
sterile 0.45-mm-pore-size filter. Filters were incubated at 378C on LB plates
overnight, and then removed from the plates and washed with 50 mM potassium
phosphate, pH 7. Washed cells were concentrated by centrifugation and sus-
pended in 1 ml of the same buffer, and 100 ml was plated on selective medium.
Plates were incubated at 378C for up to 60 h. Transconjugants which were Tcr
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and Cbs were assumed to be double crossovers in which the chromosomal
wild-type crc gene was replaced by the mutant crc gene encoding a C-terminal
deletion of the Crc coding sequence. Pseudomonas strain 8023, carrying the crc
mutation, was constructed as follows: an ApaI restriction site was introduced at
codon 35 of the Crc coding sequence (see Fig. 1) by using an in vitro oligonu-
cleotide mutagenesis kit (Amersham Corporation, Arlington Heights, Ill.). Then
the 0.5-kb ApaI-PvuII fragment with 59 and 39 deletions of the crc gene was
cloned into pUC19mob to create pPZ471. pPZ471 was introduced into P. aerugi-
nosa PAO1 as described above, and Cbr transconjugants were selected and
assumed to be single crossovers in which the chromosomal wild-type crc gene was
replaced by tandem crc alleles, one containing a C-terminal and one containing
an N-terminal deletion of the Crc coding sequence.
Transformation was employed to move plasmids into E. coli and P. aeruginosa.
E. coli was made competent by the CaCl2 procedure (21). P. aeruginosa strains
were made competent by a similar procedure but with MgCl2 substituted for
CaCl2 (19).
Plasmid isolation, mapping, and subcloning. All procedures were essentially
as described in Maniatis et al. (21). Plasmids were propagated in E. coli DH5a.
DNA sequencing. DNA sequencing was carried out by the dideoxy chain
termination method by using Taq polymerase as described by the manufacturer
(Promega Corporation, Madison, Wis.). The reaction mixtures included 7-Deaza
dGTP and were run on polyacrylamide gels containing 20% dimethylformamide.
Single-stranded DNA was used as the template for sequencing reactions. It was
derived from subclones in pTZ18R, produced in E. coli DH5aF9 with the helper
phage M13K07, and prepared according to the supplier of the helper phage
(Promega Corporation). Oligonucleotides prepared by the East Carolina Uni-
versity School of Medicine Biotechnology Program DNA Synthesis Core Labo-
ratory were used to sequence both DNA strands. Additional DNA sequencing
was done by the automated DNA sequencing facility at the University of North
Carolina, Chapel Hill.
Sequence analyses.Nucleotide and protein sequence analyses were carried out
using the University of Wisconsin Genetics Computer Group software package
and the Basic Local Alignment Search Tool (BLAST) Network Service at the
National Center for Biotechnology Information, National Institutes of Health
(2).
Enzyme assays.Measurements of [14C]mannitol uptake and incorporation and
glucose-6-phosphate dehydrogenase and amidase activities were described pre-
viously (19). Glucose-6-phosphate dehydrogenase was measured by using the
soluble fraction from crude cell extracts. Extract preparation is described below.
Mannitol uptake and amidase activities were measured with washed whole cells.
Apurinic/apyrimidinic (AP) endonuclease assays were done with partially de-
purinated plasmid DNA and analyzed by gel electrophoresis (3). Purified human
Ref-1 used as a control was the generous gift of Steven Xanthodakis (Roche
Biomedical, Nutley, N.J.). Additional AP endonuclease assays were performed in
the laboratory of Miriam Sander (NIEHS, Research Triangle Park, N.C.) by
using a synthetic oligonucleotide substrate (25). Exonuclease assays were per-
formed on linearized plasmid DNA with E. coli ExoIII (Promega Corporation)
as a positive control (3).
Expression of the crc gene product in P. aeruginosa and E. coli. To express the
crc gene product in P. aeruginosa, the 922-bp fragment (pPZ448) (see Fig. 1) was
cloned into pEB16, placing the Crc coding sequence downstream of a T7 pro-
moter (5). The resulting plasmid, pPZ456, was transformed into P. aeruginosa
ADD1976, which contains the T7 polymerase under the control of the lac
promoter on the chromosome (4). To achieve maximum expression of the crc
gene product, ADD1976 containing pPZ456 was grown for several generations in
LB medium and, at an optical density at 600 nm of 0.8, 2 mM isopropylthio-b-
D-galactopyranoside (IPTG) was added. After continued growth for 4 h at 378C,
rifampin (200 mg/ml) was added, and the cells were incubated for another 4 h.
The cells were harvested by centrifugation, suspended in 20 mM Tris, pH 6.8,
and disrupted in a French pressure cell at 16,000 psi. The cell envelope was
removed by centrifugation at 200,000 3 g, and the resulting supernatant was
loaded onto a column containing Macro-Prep High Q anion exchange resin
(Bio-Rad Laboratories, Hercules, Calif.). The column was washed with 2 column
volumes of 20 mM Tris, pH 6.8; this was followed by 1 column volume of 20 mM
Tris, pH 6.8, containing 100 mM NaCl. Subsequently, the Crc protein was eluted
with 20 mM Tris, pH 6.8, containing 160 mM NaCl.
For expression of the crc gene product in E. coli, the crc gene was cloned into
the vector pQE32 (Qiagen Inc., Chatsworth, Calif.). This vector contains a T5
promoter, two lac operators, and a ribosome binding site at the appropriate
distance from an ATG codon. It also places six histidine residues at the N
terminus of the gene product, allowing the specific binding of the expressed
protein to a nickel-nitrilo-tri-acetic acid (Ni-NTA) resin. In order to insert the crc
gene in frame with the ATG, a KpnI site was introduced 6 bp upstream of the crc
initiation codon by using an oligonucleotide-directed in vitro mutagenesis system
(see above). The crc gene was then excised as an 883-bp KpnI-StuI fragment
which was inserted into the KpnI-SmaI site in the vector pQE32. The resulting
Crc fusion protein produced from this plasmid contains an additional 20 amino
acids (including the six histidines added by the vector) at the N terminus. pQE32
containing the crc gene, pPZ461, was transformed into E. coli M15 which also
contained a second plasmid with the lacIq gene, permitting tight control of crc
gene expression in the absence of IPTG. These cells were grown to an optical
density at 600 nm of approximately 0.8 in LB medium, at which time 2 mM IPTG
was added and growth was continued for an additional 4 h. The culture was
harvested by centrifugation, suspended in 100 mM Tris, pH 7.4, and soluble cell
extracts were prepared as above. The Crc fusion protein was purified on a
Ni-NTA column used as recommended by the supplier (Qiagen).
Analysis of cell extracts by SDS-polyacrylamide gel electrophoresis. To isolate
soluble protein fractions, cells were disrupted in a French pressure cell at 16,000
psi and centrifuged at 200,000 3 g for 30 min. The resulting supernatants were
solubilized in an equal volume of sample buffer, heated to 1008C for 5 min, and
run on sodium dodecyl sulfate (SDS) polyacrylamide gels (19).
Protein sequencing. Sequencing was performed in the East Carolina Univer-
sity School of Medicine Biotechnology Program Protein Sequencing Core Lab-
oratory on a Milligen-Biosearch Model 6625 Prosequencer (Millipore Corp.,
Marlborough, Mass.). For each run, 10 mg of protein was coupled to a diisothio-
cyanate disk.
Antibody production. Crc fusion protein (500 mg) was combined with 2 vol-
umes of complete Freund’s adjuvant and injected intramuscularly into a New
Zealand White rabbit. The rabbit was boosted in a similar fashion with 500 mg of
the same protein mixed with incomplete Freund’s adjuvant and, finally, boosted
twice more with 50 mg of the protein alone, injected subcutaneously.
Western blots (immunoblots). Purified Crc protein or cell extracts from the
various Pseudomonas or E. coli strains were run on SDS polyacrylamide gels, and
proteins were transferred to Immobilon-P membranes (Millipore Corp., Bed-
TABLE 1. Strains and plasmids used
Strain or
plasmid
Relevant
characteristics
Source or
reference
P. aeruginosa
PAO1 Prototroph Holloway,a 13
PAO8005 crc-5 rec-102 18
PAO8007 crc-20 rec-102 18
PAO8020 Dcrc::Tcr This study
PAO8023 crc::Cbr This study
PRP701 crc-1 47
ADD1976 T7 polymerase, lac promoter Darzins,b 5
P. fluorescens ATCC 33512, prototroph ATCCc
P. putida PPN1225, Rifr Holloway
E. coli
DH5a f80d/lacZDM15 D(lacZYA-araF)recA GIBCO/BRLd
M15 lac ara gal mtl Qiagene
BW287 dut-1 xth A3(Ts) Weiss,f 8
BW549 dut-1 xth A3(Ts) nfo Weiss, 8
S17-1 RP4-2 Tc::Mu Km::Tn7 Tpr Smr pro 39
Plasmids
pTZ18R lacZ, a-peptide, Ampr f f1ori Pharmaciag
pUC19mob mob from pRP4 in pUC19 Lory,h 26
pEB16 T7 promoter Darzins, 5
pQE32 T5 promoter, lacO, RBS,i 6 His Qiagen
pUCP18 multicopy shuttle vector Ampr West,j 46
pKF812 vfr gene in pUCP18 West, 46
pPZ343 oriV in pTZ18R 19
pPZ352 PstI-EcoRV, crc1 in pPZ343 This study
pPZ353 SstI-EcoRV, crc1 in pTZ18R 19
pPZ354 SstI-EcoRV, crc1 in pPZ343 19
pPZ407 Dcrc::Tcr in pUC19mob This study
pPZ441 Dcrc in pPZ343 This study
pPZ445 SstI-ApaI, crc1 in pPZ343 This study
pPZ448 SstI-StuI, crc1 in pPZ343 This study
pPZ456 SstI-StuI, crc1 in pEB16 This study
pPZ461 KpnI-StuI, crc1 in pQE32 This study
pPZ471 59, 39 Dcrc in pUC19mob This study
pKK223/
HAP1
ref-11 in pKK223 Hickson,k 31
a B. Holloway, Monash University, Melbourne, Australia.
b A. Darzins, Ohio State University, Columbus.
c American Type Culture Collection, Rockville, Md.
d GIBCO/BRL Life Technologies, Gaithersburg, Md.
e Qiagen Inc., Chatsworth, Calif.
f B. Weiss, The Johns Hopkins University, Baltimore, Md.
g Pharmacia LKB Technologies, Piscataway, N.J.
h S. Lory, University of Washington, Seattle.
i rbs, ribosome binding site.
j S. West, University of Wisconsin, Madison.
k I. Hickson, University of Oxford, Oxford, England.
5628 MACGREGOR ET AL. J. BACTERIOL.
ford, Mass.). Visualization of the transferred antigens was carried out as de-
scribed by Ey and Ashman (10) with the following minor modifications. After
blocking, the membranes were incubated with (i) anti-Crc rabbit serum (or
nonimmune serum), (ii) goat anti-rabbit immunoglobulin G biotin conjugate
(Sigma Chemical Co., St. Louis, Mo.), and (iii) alkaline phosphatase-streptavidin
(Zymed Labs, San Francisco, Calif.).
Nucleotide sequence accession numbers. The 3.1-kb DNA sequence of the crc
region has been assigned GenBank accession number U38241. The sequence
between the SstI and StuI sites (55 to 976 in Fig. 4) containing the Crc coding
sequence was assigned GenBank accession number L12038.
RESULTS
Nucleotide sequence of the crc region. In previous cloning
experiments (19), we identified a 2-kb piece of P. aeruginosa
chromosomal DNA that was able to restore a wild-type phe-
notype to crc mutants (i.e., plasmid pPZ354). This DNA codes
for a protein with a molecular mass of approximately 30 kDa,
assumed to be the crc gene product (19). We sequenced 3 kb
of the crc region and found three genes, crc, pyrE, and a novel
P. aeruginosa gene which we have designated rph (Fig. 1). Since
the crc gene was known to be linked to pyrE (19), it was no
surprise to find the coding sequence for orotate phosphoribo-
syl transferase, the gene product of pyrE. On the other side of
crc the DNA sequence encodes a protein with 68% identity to
the RNase PH of E. coli. Given that the rph gene of E. coli
(encoding RNase PH) is adjacent to pyrE, we have named this
the rph gene for P. aeruginosa. Figure 2 compares the deduced
amino acid sequences of orotate phosphoribosyl transferase
and RNase PH with their E. coli homologs.
The nucleotide sequence of the crc gene and the predicted
amino acid sequence of the Crc protein are shown in Fig. 3.
Amino acid analysis of the purified crc gene product (see
below) demonstrated that protein synthesis initiates at the
ATG located at position 97. All of these genes show a strong
bias for G/C residues in the third base of their codons (Crc,
81%; PyrE, 86%; and Rph, 91%) consistent with other genes
expressed in P. aeruginosa. A potential ribosome binding site
(GGGGG) was identified 7 to 11 bp upstream of the ATG for
Crc. This is an atypical ribosome binding site for P. aeruginosa
and might explain the lower expression of the crc gene in E.
coli (see below). A stop codon (TGA) at position 874 produced
an open reading frame (ORF) of 777 bp. A protein produced
from this ORF would have a molecular mass of 28.5 kDa, in
close agreement with the 30-kDa protein identified on SDS
polyacrylamide gels (19). At positions 894 to 919, 18 bp after
the stop codon, a strong factor-independent transcriptional
terminator 26 bp in length was identified by using the TER-
MINATOR program. The PEPTIDESTRUCTURE program
predicts that the Crc protein is very hydrophilic, which is con-
sistent with the identification of this gene product in the solu-
ble fraction of P. aeruginosa (19).
FIG. 1. A summary of the 3.1-kb crc region. Identified genes and the orientation of their coding sequences are indicated. Subclones of this region which complement
crc are indicated (crc1 summarized from Fig. 2). pPZ352 was constructed by subcloning a 3.1-kb PstI-EcoRV fragment from pPZ341 into pPZ343 (19). Vector pPZ343
is pTZ18R containing a broad-host-range origin (oriV) derived from pRO1614 (28) to allow replication in Pseudomonas spp. The construction of pPZ354 was described
previously (19) (plasmid pPZ353 is identical except that it lacks an oriV). pPZ441 was constructed by isolating a 1.2-kb RsaI fragment from pPZ354 and inserting this
into the SmaI site of pPZ343. pPZ445 was created by deleting a 0.7-kb ApaI-SmaI fragment from pPZ354. pPZ448 was created by deleting a 1-kb StuI-SmaI fragment
from pPZ354. In all plasmids, except pPZ352, the lac promoter of the vector is in the same orientation as crc. The location of the tetracycline resistance cassette used
to disrupt the crc gene is indicated. p, location of the engineered ApaI site subsequently used in the construction of the crc deletion strain PAO8023.
FIG. 2. Homology between E. coli and P. aeruginosa pyrE and rph gene
products. (A) Alignment of orotate phosphoribosyl transferase sequences (pyrE).
(B) Alignment of RNase PH sequences (rph).
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Genetic identification of the crc structural gene. In order to
confirm our identification of the crc gene, we subcloned the crc
region and tested these clones for complementation of the crc
mutation. In addition we have constructed new defined muta-
tions (knockouts) of the chromosomal copy of crc.
PAO1 (wild type) shows repression of the mannitol pathway
and amidase when grown in the presence of succinate plus the
appropriate inducer. However, these activities are not re-
pressed in crc mutants (46). When a plasmid carrying the crc
gene is introduced into crc mutants, these activities become
sensitive to repression by succinate and are lowered to the
levels seen in the wild type (19). Figure 1 summarizes the
complementation results that are presented in Fig. 4. The
smallest plasmid able to restore a wild-type phenotype to the
crc mutants was pPZ448. This plasmid contained an SstI-StuI
fragment 922 bp in length. When soluble proteins from
PAO8007 containing pPZ448 or the original 2-kb subclone,
pPZ354, were analyzed on SDS polyacrylamide gels stained
with Coomassie blue, a major band in both of these extracts
had an approximate molecular mass of 30 kDa (data not
shown) (19). This band was not present in PAO8007 contain-
ing only the vector. This confirmed our previous conclusion
(19) that the crc gene product has a molecular mass of approx-
imately 30 kDa.
To create new crc mutants, the crc gene was disrupted by
replacing the 0.3-kb AccI fragment from the insert in pPZ354
(see Fig. 1) with a tetracycline resistance cassette and inserting
this defective crc gene into the chromosome of PAO1 by ho-
mologous recombination. This construction deleted the last 24
bp from the end of the gene as well as the terminator and some
downstream sequence. This construct was derived from
pPZ353, which is identical to pPZ354 except that it cannot
replicate in Pseudomonas spp. Figure 5 shows that this deletion
mutant, PAO8020, has a phenotype identical to other crc mu-
tants which either arose spontaneously or were produced by
chemical mutagenesis (46). Southern analysis of PAO8020
showed that it contained only a single copy of the crc gene and
that the Tcr cassette was located within this gene (3). The
wild-type phenotype could be restored to PAO8020 by trans-
formation with both pPZ354 and pPZ448 (Fig. 3). Thus the
DNA contained within the 922-bp SstI-StuI fragment is suffi-
cient to complement this mutation.
We subsequently constructed a second strain, PAO8023, by
recombination of a 59- and 39-deleted copy of the crc gene
(containing the coding sequence for amino acids 36 to 201 of
the Crc sequence) into PAO1. PAO8023 is also phenotypically
a crc mutant (data not shown).
Homology of the crc gene product to AP endonucleases.We
compared the deduced amino acid sequence of the crc gene
product to that of other proteins by using the FASTA,
TFASTA, and BLAST programs. The only strong candidates
for related proteins belonged to a family of DNA repair en-
zymes found in both prokaryotes and eukaryotes. The repair
FIG. 3. Nucleotide sequence of the P. aeruginosa DNA fragment contained
in pPZ352, extending from 16 bp within the pyrE coding sequence to the StuI site
(976). The region underlined (894 to 919) is a strong stem-loop structure with the
properties of a factor-independent terminator. The crc structural gene starts at
the ATG at position 97. A potential Shine-Dalgarno sequence, GGGGG, is
located at positions 86 to 90.
FIG. 4. Complementation of crc mutant PAO8007 with plasmids shown in
Fig. 1. Each plasmid was transformed into PAO8007, and all strains were grown
for two generations in BSM containing 40 mM succinate plus 5 mM [14C]man-
nitol (for uptake and incorporation) or 40 mM succinate plus 20 mM lactamide
(for amidase). Assays were performed as previously described (19). Enzyme
activity in PAO1 is expressed as 100% of each specific activity (1.2 mmol/mg of
protein for amidase and 115 nmol/mg of protein for mannitol uptake). All others
are expressed as a percentage of that found in PAO1. Symbols: n, PAO1;
h, PAO8007; ^, PAO8007/pPZ354; u, PAO8007/pPZ448; d,
PAO8007/pPZ445;s, PAO8007/pPZ441.
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enzymes in this family include human Ref-1 (redox factor) (45,
49), bovine BAP1 (bovine AP endonuclease) (32), Drosophila
Rrp1 (recombination repair protein) (34, 35), Arabidopsis
thaliana Arp (apurinic endonuclease-redox protein) (4), E. coli
ExoIII (exonuclease) (36), Streptococcus pneumoniae ExoA
(exonuclease) (30), and Bacillus subtilis ExoA (exonuclease)
(27). They range in identity to Crc from 25 to 32% and in
similarity to Crc from 51 to 57%. Homologies in these same
ranges are found when the prokaryotic enzymes are compared
with the eukaryotic enzymes or when the prokaryotic enzymes
are compared with each other. Areas of identity are not lo-
cated at a particular region of each protein but exist through-
out all these proteins, including Crc. These homologies are
illustrated in Fig. 6. All these proteins (with the exception of B.
subtilis ExoA which has yet to be isolated) possess AP endo-
nuclease activity and are theorized to be involved in some way
in DNA repair. Recently, an ORF was identified in Coxiella
burnetii (44) which codes for a putative protein with a 44%
identity to crc. This putative protein is also shown in Fig. 6. In
C. burnetii this ORF is adjacent to a homolog of orotate phos-
phoribosyl transferase. It is intriguing to note that this ORF
and crc are adjacent to and divergently expressed from the
orotate phosphoribosyl transferases. In P. aeruginosa there are
80 bp between the ATG start codons for pyrE and crc, while in
C. burnetii there are 50 bp between ATGs.
As an initial test for a DNA repair activity in the Crc protein,
we compared the sensitivities of P. aeruginosa PAO1 (crc1),
PAO8007 (crc-20), and PAO8020 (Dcrc) to DNA damaging
agents. E. coli xth (ExoIII) mutants are extremely sensitive to
alkylating agents such as methyl methanesulfonate and mito-
mycin C and oxidizing agents such as H2O2 (8). At concentra-
tions of these agents which caused a decrease in survival of
PAO1 of less than 1 log, no greater sensitivity was observed in
either PAO8007 or PAO8020 (data not shown).
Since there may be redundant recombination repair activi-
ties in Pseudomonas spp. that would mask the phenotype of a
single mutation, we also tested the Crc protein for AP endo-
FIG. 5. Complementation of crc mutant PAO8020 with crc1 plasmids shown
in Fig. 1. Plasmids pPZ448 and pPZ354 and the vector, pPZ343, were trans-
formed into PAO8020, and all strains were grown for two generations in BSM
containing 40 mM succinate plus 5 mM [14C]mannitol (for uptake and incorpo-
ration), 40 mM succinate plus 20 mM mannitol (for glucose-6-phosphate dehy-
drogenase), or 40 mM succinate plus 20 mM lactamide (for amidase). Assays
were performed as previously described (19). Enzyme activity in PAO1 is ex-
pressed as 100% of specific activity (0.83 mmol/mg of protein for amidase, 10.4
nmol/mg of protein for glucose-6-phosphate dehydrogenase, and 215 nmol/mg of
protein for mannitol uptake). All others are percentages of that found in PAO1.
Symbols: n, PAO1; h, PAO8007; ^, PAO8020; u, PAO8020/
pPZ343;‘, PAO8020/pPZ448;s, PAO8020/pPZ354.
FIG. 6. Comparison of Crc to AP endonucleases. Alignment was made using
the PILEUP program. The consensus sequence contains those amino acids
present in five of the nine sequences compared. Capitalized amino acids are
similar or identical to the consensus. The alignments begin at amino acids 62 for
Ref-1, 61 for BAP1, 427 for Rrp1, and 267 for Arp. All the remaining (prokary-
otic) sequences begin at the amino terminus.
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nuclease activity in vivo by using two E. coli mutants. E. coli
strains BW287 and BW549 contain a temperature-sensitive
mutation in the xth gene (ExoIII), giving them lower survival
rates at increased growth temperatures (8, 44). Both strains
contain a dut-1 mutation to generate AP sites in the DNA.
BW549 also contains a mutation in the nfo gene which codes
for endonuclease IV, giving it an even lower survival rate than
BW287 (8). Previous studies indicated that other genes in this
AP endonuclease family (ref-1 and rrp1) can replace the xth
gene in these mutants and restore wild-type survival rates at
elevated temperature (12, 31). We performed a similar exper-
iment by comparing the plating efficiency of BW287 and
BW549 carrying plasmids containing the ref-1 gene, the crc
gene, and the crc fusion gene (crc-f) with the plating efficiency
of each of these strains carrying no plasmid or vector only.
Table 2 shows that neither form of the crc gene could replace
the temperature-sensitive ExoIII protein at 428C, while the
Ref-1 protein could. To confirm that the crc gene was actually
being expressed in these E. coli strains, Western blots were
performed (as described below). In both strains containing the
crc or crc-f genes, a band was recognized by the anti-Crc anti-
sera at the correct location. No band was observed in the
controls (3).
Expression of the purified crc gene product.We purified two
crc gene products, a native Crc expressed in P. aeruginosa and
a fusion protein expressed in E. coli. After placement of the crc
gene behind a T7 promoter in pEB16 (creating pPZ456), the
Crc protein became the major protein in soluble extracts of P.
aeruginosaADD1976 following induction of the T7 polymerase
with IPTG (Fig. 7B). This protein had a MW of approximately
30 kDa, which was identical to that identified as the crc gene
product produced in P. aeruginosa from pPZ354 (reference 19
and above). The native protein was purified to approximately
60% purity, allowing for the identification of the following 10
amino acids from the N terminus: M-R-I-I-S-V-N-V-N-G.
These 10 amino acids are in exact agreement with the nucle-
otide sequence presented in Fig. 3. This purified protein was
also recognized by antibodies prepared against the Crc fusion
protein purified from E. coli (see below).
In E. coli M15, the crc gene product was produced from
pPZ461 (Fig. 7A). Although the amount of Crc fusion protein
produced in E. coli from this plasmid was increased over our
original attempt (19), it was less than that produced in P.
aeruginosa (compare lane 4 with lane 10 in Fig. 7). The vector,
pQE32, contains lac and T5 promoters and a ribosome binding
site which is followed by a multiple cloning site which allows
for in-frame cloning of a desired gene after six histidine
codons. The fusion protein produced from this vector contain-
ing the crc gene was slightly larger than 30 kDa because of the
added six histidines and the amino acids added at the N ter-
minus to allow placement of the gene in frame with the histi-
dine codons. Purification of the fusion protein over a Ni-NTA
column resulted in a preparation which was greater than 95%
pure. When the complete amino acid composition of this fu-
FIG. 7. SDS polyacrylamide gels showing expression and purification of the
crc gene product from pPZ461 in E. coliM15 and from pPZ456 in P. aeruginosa
ADD1976. Cells were grown as described in Materials and Methods either with
(1) or without (2) IPTG. The crude soluble protein fractions and purified
fractions (see Materials and Methods) were solubilized in sample buffer and run
on SDS polyacrylamide gels (19) which were stained with Coomassie blue.
Molecular mass markers contain proteins of 97, 66, 45, 30, 21, and 14 kDa. The
30-kDa band is labeled. (A) Crc fusion protein purified from E. coliM15. Lanes
on either end contain molecular mass markers. Lane 1, crude soluble fraction
fromM15 (1); lane 2, crude soluble fraction fromM15 containing vector pQE32
(1); lane 3, crude soluble fraction from M15 containing pPZ461 (2); lane 4,
crude soluble fraction from M15 containing pPZ461 (1); lanes 5 and 6 contain
244 ng and 540 ng, respectively, of Crc fusion protein purified by elution from the
Ni-NTA column. Samples of crude extracts contained 4 to 6 mg of protein. (B)
Native Crc purified from P. aeruginosa. Lanes on either end contain molecular
mass markers. Lane 7, crude soluble fraction from ADD1976 (1); lane 8, crude
soluble fraction from ADD1976 containing vector pEB16 (1); lane 9, crude
soluble fraction from ADD1976 containing pPZ456 (2); lane 10, crude soluble
fraction from ADD1976 containing pPZ456 (1); lane 11 contains 260 ng of
partially purified Crc protein. Samples of crude extracts contained 6 to 7 mg of
protein.
TABLE 2. Complementation analysis of E. coli ExoIII mutants with
cloned P. aeruginosa crc and crc-fa genes and the human ref-1 gene
Strain (plasmid, gene) Relative platingefficiencyb
BW287 1.2 3 1023
BW287 (pKK223-HAP1, ref-1) 0.93
BW287 (pPZ343, vector) 2.53 1023
BW287 (pPZ353, crc) 5.0 3 1023
BW287 (pQE32, vector) 1.53 1023
BW287 (pPZ461, crc-f) 3.2 3 1023
BW549 3.0 3 1025
BW549 (pKK223-HAP1, ref-1) 0.82
BW549 (pPZ343, vector) 4.03 1025
BW549 (pPZ353, crc) 5.0 3 1025
BW549 (pQE32, vector) 3.53 1025
BW549 (pPZ461, crc-f) 3.8 3 1025
a crc fusion gene.
b Cells were grown to late log phase in 23 YT (yeast extract-tryptone) medium
(21). They were concentrated 253 by centrifugation and suspended in 50 mM
potassium phosphate, pH 7.5. Samples of serial 103 dilutions were plated on two
identical 23 YT plates. (Plates for strains carrying plasmids contained ampicil-
lin.) One plate of each pair was incubated at 308C, the other was incubated at
428C. The numbers of colonies appearing on the plates were counted after 24 h.
The relative plating efficiency is expressed as the ratio of the number of colonies
growing at 428C and 308C.
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sion protein was determined, it was found to be in close agree-
ment with the amino acid composition predicted from the
nucleotide sequence (3).
We assayed both the purified native Crc protein and the
fusion protein for both AP endonuclease and for exonuclease
activities. Neither activity could be identified in either Crc
protein, although we were able to detect AP endonuclease
activity in purified human Ref-1 and both activities in purified
E. coli ExoIII (3).
Detection of Crc in Pseudomonas species. Purified Crc fusion
protein from E. coli was used to produce polyclonal antibody in
a rabbit. Western blots were performed with this antiserum to
look for antigenically similar proteins in crude soluble cell
extracts from P. putida and P. fluorescens. Sera from nonim-
mune rabbits served as a control for specificity of the anti-Crc
antibody. Figure 8 shows that crude extracts from the Pseudo-
monas strains each have a protein that is recognized only by
anti-Crc antibody. These proteins from both strains have mo-
lecular weights similar to Crc. No protein which reacted spe-
cifically with anti-Crc antibody could be found in crude extracts
from E. coli (3).
This same anti-Crc antiserum was used to look for the pres-
ence of Crc protein in crude extracts of crc mutants. Figure 9
shows that the knockout mutant, PAO8020, described above
lacks a cross-reacting 30-kDa protein. Our second knockout,
PAO8023, also lacks a cross-reacting 30-kDa protein (data not
shown). Of two other mutants produced by chemical mutagen-
esis (47), PAO8005 contains a very small amount of the 30-kDa
protein, while PAO8007 produces a 30-kDa protein which we
assume to be nonfunctional. Both of these mutants are com-
plemented by a 2-kb DNA fragment containing the crc1 gene
and have a phenotype identical to PAO8020 (19). PRP701 is a
spontaneous crc mutant which also has a phenotype identical
to PAO8005, PAO8007, and PAO8020 (48). This mutant also
presumably contains a defective Crc protein.
Crc is distinct from E. coli Cap. Recently, West et al. iden-
tified a gene from P. aeruginosa, vfr, which has 67% identity
and 91% similarity to the E. coli crp gene and which comple-
ments the E. coli crp mutation (46). To confirm that the Crc
protein does not function in the same manner as the Cap
protein in E. coli (also known as Crp), we attempted to com-
plement the crc mutation with the vfr gene. The crc mutants,
PAO8007 and PAO8020, were transformed with the vector
pUCP18 and with the same vector carrying the vfr gene,
pKF812. Each of these was grown in BSM-succinate plus man-
nitol or BSM-succinate plus lactamide, and the activities of
mannitol dehydrogenase, glucose-6-phosphate dehydrogenase,
and amidase were measured. In contrast to the complementa-
tion data shown in Fig. 4 and 5, all of these activities were
identical and independent of the plasmid present (17). The
wild-type phenotype was not restored by the vfr1 plasmid as it
was by the crc1 plasmids shown in Fig. 2 and 3. Thus, the
function of the Crc protein could not be replaced by the vfr
gene product.
Since the phenotype of the crc mutants suggests the loss of
a regulatory protein, we compared the sequence of Crc with
that of other regulatory proteins. No significant homology was
found to Cap from E. coli or to any other DNA-binding pro-
tein. The MOTIFS program was also used to look for helix-
loop-helix regions, common to DNA-binding proteins. No such
regions were identified. No regions of the protein similar to
any other sequence pattern in the Prosite database were found
(at the level of zero mismatches). Nor were any matches found
by using the PROFILESCAN program, which looks for struc-
tural and sequence motifs within proteins. For all searches, the
entire amino acid sequence of the crc gene product was used as
well as smaller portions of this sequence.
FIG. 8. Identification of a protein antigenically similar to Crc in crude ex-
tracts from P. putida and P. fluorescens. Crude extracts were prepared from
log-phase cultures of Pseudomonas spp. grown on LB medium. Samples of each
extract containing 8 to 9 mg of protein were run on SDS polyacrylamide gels (see
Materials and Methods). Western blot analysis was performed as described in
Materials and Methods. Bands shown in panel A were visualized with anti-Crc
antiserum and those shown in panel B were visualized with nonimmune serum.
Prestained molecular mass markers of 19, 28, 33, 50, 80, and 106 kDa are shown
in the left lane. Because of the bound stain, these markers migrate more rapidly
than the unstained markers. Lanes 1 and 5 contain extracts from P. aeruginosa,
lanes 2 and 6 contain extracts from P. putida, lanes 3 and 7 contain extracts from
P. fluorescens, and lanes 4 and 8 contain 50 ng of partially purified native Crc
protein from P. aeruginosa. The arrow in panel B indicates the position of the Crc
protein, just above the 33-kDa marker.
FIG. 9. Identification of Crc protein in PAO1 and various crc mutant strains.
Crude cell extracts from wild-type and mutant cultures were prepared from
LB-grown cultures, run on SDS polyacrylamide gels, and analyzed by Western
blotting as shown in Fig. 7. The region of the gel containing proteins which
reacted only with anti-Crc antiserum (not with preimmune serum) are shown.
The left lane shows the 28- and 33-kDa markers. Lane 1, extract from PAO1;
lane 2, extract from PAO8005 (crc-5); lane 3, extract from PAO8007 (crc-20);
lane 4, extract from PAO8020 (Dcrc); lane 5, extract from PRP701 (crc-1).
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DISCUSSION
We have isolated and sequenced 3.1 kb of P. aeruginosa
chromosomal DNA which contains three genes, pyrE, rph, and
crc. We have shown that a 922-bp fragment complements pre-
viously described crc mutants (19). These mutants lack a gene
essential for catabolite repression control. When the 922-bp
sequence was interrupted with a tetracycline resistance gene
and the defective crc gene was inserted into the chromosome
of wild-type strain PAO1, a mutant with a phenotype identical
to the original mutants was generated. Western analysis of
crude extracts of this mutant showed that it lacked the 30-kDa
protein. The construction of this knockout should produce an
almost full-length Crc protein (lacking eight amino acids), sug-
gesting that the truncated protein is unstable in P. aeruginosa.
The 922-bp fragment contains an ORF encoding a protein of
259 amino acids with a relative molecular mass of approxi-
mately 28.5 kDa. Eighteen base pairs following the TGA stop
codon is a strong factor-independent transcriptional termina-
tor which is 26 bp in length. A potential ribosome binding site
was identified upstream of the initiating ATG; however, this
site was unique in that it contained only G residues. This lack
of a typical E. coli ribosome binding site may provide a partial
explanation for the low level of expression of the crc gene in E.
coli, even from a strong promoter (19). However, even when an
appropriate ribosome binding site was provided in pPZ461,
Crc represented a smaller percentage of the total protein in E.
coli than in P. aeruginosa. Crc protein was purified from P.
aeruginosa, and analysis of the first 10 amino acids are in exact
agreement with those predicted from the DNA sequence.
A comparison of the predicted crc gene product to other
known protein sequences led to the surprising finding that this
protein shows homology to a group of DNA repair enzymes;
however, all attempts to show that the Crc protein functions as
an endonuclease proved negative. crc mutants show no in-
creased sensitivity to DNA damaging agents, and the crc gene
cannot complement E. coli xth or nfomutants. The purified Crc
proteins lack both endonuclease and exonuclease activity. Ex-
onuclease activity is a feature of the bacterial enzymes belong-
ing to this group. This suggests that, although the Crc protein
may be related to this family of endonucleases, it does not have
the same activity. Crc appears to be most closely related to the
C. burnetii putative protein, with more similarity in the C-
terminal region where Crc is less similar to the endonucleases
(see Fig. 6). This suggests that these two proteins may have the
same function. Perhaps, like the Ref-1 protein, the Crc protein
has a regulatory function and a second function involved in
DNA modification. Ref-1 stimulates the DNA-binding activity
of the Fos and Jun transcription factors by an unknown mech-
anism and has endonuclease activity (45, 49).
In order to identify a regulatory mechanism for the Crc
protein, we have also tested both native and fusion Crc pro-
teins for their ability to bind to small DNA fragments contain-
ing upstream regions of several Crc-regulated genes involved
in carbohydrate catabolism. To date, gel shift assays indicate
that the Crc protein has no specific DNA-binding activity. The
possibility exists that this lack of binding is due to the absence
of a cofactor required for binding of the Crc protein to the
DNA. Therefore, experiments were carried out to look for
DNA binding in the presence of various metabolites. Included
in the binding mixtures were the following: acetyl coenzyme A,
coenzyme A, AMP, ADP, ATP, cAMP, GTP, NAD-NADH,
NADP-NADPH, and glutathione. Each was added to a sepa-
rate Crc-DNA mixture, and binding was assayed by gel shift. In
no case were we able to find any DNA-binding activity with
native or fusion Crc protein (3). Positive controls included a
binding activity found in crude extracts of wild-type and crc
mutant strains which does bind to these same regulatory re-
gions of P. aeruginosa DNA (3).
To demonstrate that the Crc protein functions in a different
manner from E. coli Cap, we attempted to replace the defec-
tive Crc protein in crc mutants with the P. aeruginosa homolog
of E. coli Cap. As expected, the vfr gene, which does comple-
ment E. coli crpmutants (46), did not complement crcmutants.
Thus, the Crc protein has been examined for modes of
action suggested by its sequence and by its function. It has been
exhaustively tested for endonuclease, exonuclease, and DNA-
binding activities and was found to possess none of these.
Moreover, the predicted amino acid sequence for the Crc
protein showed no significant homology to any other protein(s)
other than this family of eukaryotic and prokaryotic DNA
repair enzymes, nor did it contain a structural motif common
to any group of proteins in the Prosite bank. The actual mech-
anism of action of the Crc protein in catabolite repression
control is likely to be quite different from that of any previously
described prokaryotic regulatory protein. Perhaps, like Ref-1,
instead of binding directly to DNA itself, it regulates gene
expression by activating a DNA-binding protein. This could
explain its ability to regulate multiple independent catabolic
systems. Whatever its mechanism, it is likely that the same
catabolite repression control system exists in the fluorescent
pseudomonads, since we were able to identify proteins which
were antigenically similar to Crc in P. putida and P. fluorescens
but not in E. coli. The existence of a common mechanism of
catabolite repression control in these closely related species is
not surprising, since repression by organic acids has been ob-
served in all three species (16, 42).
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